7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To examine the effect of conditional survival on 5-year cancer-specific survival (CSS) probability after radical nephroureterectomy (RNU) in a contemporary cohort of patients with non-metastatic urothelial carcinoma of the upper urinary tract (UTUC).

          Related collections

          Author and article information

          Journal
          J Surg Oncol
          Journal of surgical oncology
          Wiley
          1096-9098
          0022-4790
          Jun 2020
          : 121
          : 7
          Affiliations
          [1 ] Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
          [2 ] Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
          [3 ] Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Brescia, Italy.
          [4 ] Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
          [5 ] Department of Urology,San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.
          [6 ] Department of Urology, European Institute of Oncology, Milan, Italy.
          [7 ] Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
          [8 ] Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
          [9 ] Institute of Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
          Article
          10.1002/jso.25877
          32107785
          72a5a74f-42da-47bc-9cd1-6b8e9e5c2ae6
          History

          survival benefit,disease stage,SEER database,epidemiology,tumor characteristics

          Comments

          Comment on this article